The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 04, 2023

Filed:

Nov. 26, 2018
Applicant:

Immatics Us, Inc., Houston, TX (US);

Inventors:

Monique Dao, Houston, TX (US);

Steffen Walter, Houston, TX (US);

Melinda Mata, Houston, TX (US);

Aleksandra Nowicka, Houston, TX (US);

Yannick Bulliard, Houston, TX (US);

Sarah Missell, Tuebingen, DE;

Sabrina Kuttruff-Coqui, Filderstadt-Sielmingen, DE;

Norbert Hilf, Kirchentellinsfurt, DE;

Assignee:

IMMATICS US, INC., Houston, TX (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); C12N 5/0783 (2010.01); A61K 31/663 (2006.01); A61K 31/675 (2006.01); A61K 38/20 (2006.01); C07K 14/54 (2006.01); C07K 14/55 (2006.01); C12N 5/00 (2006.01); C12N 15/62 (2006.01); C12N 15/85 (2006.01); A61K 35/12 (2015.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61K 31/663 (2013.01); A61K 31/675 (2013.01); A61K 38/2013 (2013.01); C07K 14/5443 (2013.01); C07K 14/55 (2013.01); C12N 5/0018 (2013.01); C12N 5/0636 (2013.01); C12N 5/0638 (2013.01); C12N 15/62 (2013.01); C12N 15/8509 (2013.01); A61K 2035/122 (2013.01); A61K 2035/124 (2013.01); C07K 16/2809 (2013.01); C12N 2501/155 (2013.01); C12N 2501/2302 (2013.01); C12N 2501/2315 (2013.01); C12N 2501/515 (2013.01); C12N 2501/998 (2013.01); C12N 2740/10043 (2013.01);
Abstract

The present disclosure relates to expansion and activation of T cells. In an aspect, the present disclosure relates to expansion and activation of γδ T cells that may be used for transgene expression. In another aspect, the disclosure relates to expansion and activation of γδ T cells while depleting α- and/or β-TCR positive cells. T cell populations comprising expanded γδ T cell and depleted or reduced α- and/or β-TCR positive cells are also provided for by the instant disclosure. The disclosure further provides for methods of using the disclosed T cell populations.


Find Patent Forward Citations

Loading…